GeneOne Life Science/Impairment of 50% or More of Entire Capital or Sales of Less than 5 Billion (KRW)/2026.04.07

S GeneOne Life Science

[Impairment of 50% or More of Entire Capital or Sales of Less than 5 Billion (KRW)]

Toc All Select

Main Documents
Attachment Documents

Index

☞ This disclosure is under the jurisdiction of [Korea Exchange’s Securities Market Headquarters]. ☞ This is not a final document. Please be careful when making investment decisions.